Inocoterone
 | |
| Clinical data | |
|---|---|
| Other names | RU-29294; 2,5-Seco-A-dinorestr-9-en-17β-ol-5-one |
| Routes of administration | Topical |
| Drug class | Nonsteroidal antiandrogen |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H24O2 |
| Molar mass | 248.366 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Inocoterone (INN; developmental code name RU-29294) is a steroid-like nonsteroidal antiandrogen (NSAA) that was never marketed.[1][2] An acetate ester, inocoterone acetate, shows greater antiandrogen activity and was developed, as a topical medication for the treatment of acne but showed only modest effectiveness in clinical trials and similarly was never marketed.[3]
See also
[edit]References
[edit]- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 686–. ISBN 978-1-4757-2085-3.
- ^ Conn PM (23 July 2010). Techniques in Confocal Microscopy. Academic Press. pp. 215–. ISBN 978-0-12-384659-4.
- ^ Annual Reports in Medicinal Chemistry. Academic Press. 2 September 1987. pp. 358–. ISBN 978-0-08-058366-2.
 | This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |